A comparative analysis of the roles and use of evidence in pharmacy policy in Australia

Pharmacists have important roles in consumers’ access to medicines and healthcare. Pharmacy policy advocates have recognised that evidence is important but often insufficient for policy change to support expanded roles of pharmacists, but there has been minimal exploration of why this is the case. To characterise, classify, and describe the types of knowledge that were considered and used in these two pharmacy policy issues in Australia: codeine up-scheduling and pharmacist-administered vaccinations. Using documentary data and semi-structured interviews, we identified the research-based, practical, and political knowledge used in these policy processes, drawing on Head’s ‘three lenses of evidence-based policy’. We used a ‘programmatic approach’ to analyse how evidence is used in policymaking, where the use and framing of evidence is considered in light of policy actors’ institutional roles and goals. Practical knowledge demonstrating pharmacists’ ability to conduct clinical activities and political knowledge of institutional processes and acceptability were used for both issues; however, research evidence was more identifiable in up-scheduling. Evidence was prioritised and used differently depending on stakeholders’ goals. Our analysis offers insights for the Australian pharmacy sector advocating for policies to benefit individual and public health. Although medicines regulation and pharmacy practice are phenomena that exist globally, institutional and policymaking contexts differ by country. The pharmacy sector needs to consider these contexts to effectively engage policymakers and optimise evidence use in developing and implementing desired policies.

[1]  J. Webster,et al.  Understanding evidence use from a programmatic perspective: conceptual development and empirical insights from national malaria control programmes , 2020, Evidence & Policy: A Journal of Research, Debate and Practice.

[2]  P. Aslani,et al.  Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group , 2020, Research in Social and Administrative Pharmacy.

[3]  R. Tsuyuki,et al.  Pharmacy practice research - A call to action. , 2020, Research in social & administrative pharmacy : RSAP.

[4]  R. Tsuyuki,et al.  The evolution of pharmacy practice research—Part II: Time to join the rest of the world , 2019, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[5]  R. Tsuyuki,et al.  The evolution of pharmacy practice research—Part I: Time to implement the evidence , 2019, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada.

[6]  R. Tsuyuki,et al.  Evidence and its impact on pharmacy practice: Don’t be “evidence-illiterate” , 2018, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[7]  Marco Liverani,et al.  The many meanings of evidence: a comparative analysis of the forms and roles of evidence within three health policy processes in Cambodia , 2017, Health Research Policy and Systems.

[8]  M. Bouvy,et al.  From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. , 2015, Health policy.

[9]  N. Morrow Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence , 2015, Journal of pharmaceutical policy and practice.

[10]  N. Morrow Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development , 2015, Journal of Pharmaceutical Policy and Practice.

[11]  Stephanie J. C. Taylor,et al.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. , 2014 .

[12]  Lisa Bero,et al.  Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. , 2010, The Cochrane database of systematic reviews.

[13]  T. Greenhalgh,et al.  Evidence-Based Policymaking: A Critique , 2009, Perspectives in biology and medicine.

[14]  Brian Head,et al.  Three lenses of evidence-based policy , 2008 .

[15]  P. Noyce Governance and the pharmaceutical workforce in England. , 2006, Research in social & administrative pharmacy : RSAP.

[16]  A. B. Almarsdóttir,et al.  Studying and evaluating pharmaceutical policy—becoming a part of the policy and consultative process , 2006, Pharmacy World and Science.

[17]  Andy Haines,et al.  Use of research to inform public policymaking , 2004, The Lancet.

[18]  H. Lofgren,et al.  Pharmaceuticals in Australia: developments in regulation and governance. , 2004, Social science & medicine.

[19]  Rob Watts,et al.  Tampering with the evidence: a critical appraisal of evidence-based policy-making , 2003 .

[20]  C. Bond Pharmacy Practice Research: Evidence and Impact , 2015 .